Overview

Actual Use Trial of Naproxen Sodium

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
An actual use trial to demonstrate that consumers will not exceed the labeled daily dose of Aleve 24 Hour at an unacceptable rate. Two aspects of consumer use will be evaluated: 1) the frequency at which consumers exceed the label-defined daily dose, thus putting themselves at clinical risk, and 2) the reasons for exceeding the labeled daily dose.
Phase:
Phase 3
Details
Lead Sponsor:
Bayer
Treatments:
Naproxen